Altered thyroid hormone profile in offspring after exposure to high estradiol environment during the first trimester of pregnancy: A cross-sectional study

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Lv, Ping Ping ^a   Meng, Ye ^a   Lv, Min ^a   Feng, Chun ^a   Liu, Ye ^a   Li, Jing Yi ^a   Yu, Dan Qin ^a   Shen, Yan ^a   Hu, Xiao Lin ^a   Gao, Qian ^a   Dong, Shan ^a   Lin, Xian Hua ^a   Xu, Gu Feng ^a   Tian, Shen ^a   Zhang, Dan ^a   Zhang, Fang Hong ^a   Pan, Jie Xue ^a   Ye, Xiao Qun ^a   Liu, Miao E ^a   Liu, Xin Mei ^a   Sheng, Jian Zhong ^a   Ding, Guo Lian ^a,b   Huang, He Feng ^a,b   more..

^a ZHEJIANG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Early pregnancy; Embryo transfer; Estradiol; In vitro fertilization; Intrauterine environment; Offspring; Thyroid hormone; Thyroid stimulating hormone

Indexed keywords

ESTRADIOL; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ARTICLE; CHILD; CROSS-SECTIONAL STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; NEWBORN; PHYSICAL EXAMINATION; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PROGENY; RISK ASSESSMENT; THYROID DISEASE; ADULT; ADVERSE EFFECTS; BLOOD; ENVIRONMENTAL EXPOSURE; INFANT, NEWBORN, DISEASES; PREGNANCY; PRESCHOOL CHILD;

ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; THYROID HORMONES;

EID: 84924027619     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0240-0     Document Type: Article

References (45)

1. Steptoe PC, Edwards RG: Birth after the reimplantation of a human embryo. Lancet 1978, 2:366.
2. Chen M, Wu L, Zhao J, Wu F, Davies MJ, Wittert GA, Norman RJ, Robker RL, Heilbronn LK: Altered glucose metabolism in mouse and humans conceived by IVF. Diabetes 2014, 63:3189-3198.
3. Hu XL, Feng C, Lin XH, Zhong ZX, Zhu YM, Lv PP, Lv M, Meng Y, Zhang D, Lu XE, Jin F, Sheng JZ, Xu J, Huang HF: High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth. J Clin Endocrinol Metab 2014, 99:2217-2224.
4. Huang HF, Sheng JZ: Gamete and Embryo-Fetal Origins of Adult Diseases. New York, NY: Springer; 2014.
5. Kalra SK, Ratcliffe SJ, Coutifaris C, Molinaro T, Barnhart KT: Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. Obstet Gynecol 2011, 118:863-871.
6. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A: Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol 2009, 146:138-148.
7. Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE: Delemarre-van de Waal HA: Growth and development of children born after in vitro fertilization. Fertil Steril 2008, 90:1662-1673.
8. Whybrow PC, Prange AJ Jr, Treadway CR: Mental changes accompanying thyroid gland dysfunction: a reappraisal using objective psychological measurement. Arch Gen Psychiatry 1969, 20:48-63.
9. Neves C, Alves M, Medina JL, Delgado JL: Thyroid diseases, dyslipidemia, and cardiovascular pathology. Rev Port Cardiol 2008, 27:1211-1236.
10. Lidegaard O, Pinborg A, Andersen AN: Imprinting disorders after assisted reproductive technologies. Curr Opin Obstet Gynecol 2006, 18:293-296.
11. Gracia CR, Morse CB, Chan G, Schilling S, Prewitt M, Sammel MD, Mandel SJ: Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization. Fertil Steril 2012, 97:585-591.
12. Mintziori G, Goulis DG, Toulis KA, Venetis CA, Kolibianakis EM, Tarlatzis BC: Thyroid function during ovarian stimulation: a systematic review. Fertil Steril 2011, 96:780-785.
13. Poppe K, Unuane D, D'Haeseleer M, Tournaye H, Schiettecatte J, Haentjens P, Velkeniers B: Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome. Fertil Steril 2011, 96:241-245.
14. Santin AP, Furlanetto TW: Role of estrogen in thyroid function and growth regulation. J Thyroid Res 2011, 2011:875125.
15. Trueba SS, Auge J, Mattei G, Etchevers H, Martinovic J, Czernichow P, Vekemans M, Polak M, Attie-Bitach T: PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. J Clin Endocrinol Metab 2005, 90:455-462.
16. Sakka SD, Malamitsi-Puchner A, Loutradis D, Chrousos GP, Kanaka-Gantenbein C: Euthyroid hyperthyrotropinemia in children born after in vitro fertilization. J Clin Endocrinol Metab 2009, 94:1338-1341.
17. Kondapalli LA, Molinaro TA, Sammel MD, Dokras A: A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod 2012, 27:2690-2697.
18. Fleten C, Nystad W, Stigum H, Skjaerven R, Lawlor DA, Davey Smith G, Naess O: Parent-offspring body mass index associations in the Norwegian Mother and Child Cohort Study: a family-based approach to studying the role of the intrauterine environment in childhood adiposity. Am J Epidemiol 2012, 176:83-92.
19. Belkacemi L, Nelson DM, Desai M, Ross MG: Maternal undernutrition influences placental-fetal development. Biol Reprod 2010, 83:325-331.
20. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, Uauy R: Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013, 382:427-451.
21. Lakshmy R: Metabolic syndrome: role of maternal undernutrition and fetal programming. Rev Endocr Metab Disord 2013, 14:229-240.
22. Ding GL, Wang FF, Shu J, Tian S, Jiang Y, Zhang D, Wang N, Luo Q, Zhang Y, Jin F, Leung PC, Sheng JZ, Huang HF: Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes 2012, 61:1133-1142.
23. Fetita LS, Sobngwi E, Serradas P, Calvo F, Gautier JF: Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab 2006, 91:3718-3724.
24. Fagman H, Nilsson M: Morphogenetics of early thyroid development. J Mol Endocrinol 2011, 46:R33-R42.
25. Mullur R, Liu YY, Brent GA: Thyroid hormone regulation of metabolism. Physiol Rev 2014, 94:355-382.
26. Fisher DA, Nelson JC, Carlton EI, Wilcox RB: Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid 2000, 10:229-234.
27. Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES, Nestler EJ: Early life programming and neurodevelopmental disorders. Biol Psychiatry 2010, 68:314-319.
28. Wallingford JB, Niswander LA, Shaw GM, Finnell RH: The continuing challenge of understanding, preventing, and treating neural tube defects. Science 2013, 339:1222002.
29. Aviles M, Gutierrez-Adan A, Coy P: Oviductal secretions: will they be key factors for the future ARTs? Mol Hum Reprod 2010, 16:896-906.
30. Chason RJ, Csokmay J, Segars JH, DeCherney AH, Armant DR: Environmental and epigenetic effects upon preimplantation embryo metabolism and development. Trends Endocrinol Metab 2011, 22:412-420.
31. Lonergan P, Fair T: The ART of studying early embryo development: progress and challenges in ruminant embryo culture. Theriogenology 2014, 81:49-55.
32. Duntas LH: Thyroid disease and lipids. Thyroid 2002, 12:287-293.
33. Caraccio N, Dardano A, Monzani F: Subclinical thyroid disease and cardiovascular disease. JAMA 2005, 293:1059-1060. Author reply 1060.
34. Ceelen M, van Weissenbruch MM, Roos JC, Vermeiden JP, van Leeuwen FE, Delemarre-van de Waal HA: Body composition in children and adolescents born after in vitro fertilization or spontaneous conception. J Clin Endocrinol Metab 2007, 92:3417-3423.
35. Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE, Delemarre-van de Waal HA: Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab 2008, 93:1682-1688.
36. Bowdin S, Allen C, Kirby G, Brueton L, Afnan M, Barratt C, Kirkman-Brown J, Harrison R, Maher ER, Reardon W: A survey of assisted reproductive technology births and imprinting disorders. Hum Reprod 2007, 22:3237-3240.
37. Chiba H, Hiura H, Okae H, Miyauchi N, Sato F, Sato A, Arima T: DNA methylation errors in imprinting disorders and assisted reproductive technology. Pediatr Int 2013, 55:542-549.
38. Hiura H, Okae H, Miyauchi N, Sato F, Sato A, Van De Pette M, John RM, Kagami M, Nakai K, Soejima H, Ogata T, Arima T: Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. Hum Reprod 2012, 27:2541-2548.
39. Manipalviratn S, DeCherney A, Segars J: Imprinting disorders and assisted reproductive technology. Fertil Steril 2009, 91:305-315.
40. Furlanetto TW, Nguyen LQ, Jameson JL: Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 1999, 140:5705-5711.
41. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M: Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001, 86:1072-1077.
42. Banu SK, Govindarajulu P, Aruldhas MM: Testosterone and estradiol differentially regulate TSH-induced thyrocyte proliferation in immature and adult rats. Steroids 2002, 67:573-579.
43. Antico-Arciuch VG, Dima M, Liao XH, Refetoff S, Di Cristofano A: Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females. Oncogene 2010, 29:5678-5686.
44. Lima LP, Barros IA, Lisboa PC, Araujo RL, Silva AC, Rosenthal D, Ferreira AC, Carvalho DP: Estrogen effects on thyroid iodide uptake and thyroperoxidase activity in normal and ovariectomized rats. Steroids 2006, 71:653-659.
45. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS: Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006, 66:5624-5632.